The 2013 CIS Annual Meeting was held from April 25-28, 2013 at the JW Marriott Marquis in Miami, FL. A total of 389 delegates registered to attend the 2013 Annual Meeting. Just prior to the Annual Meeting an additional course was offered this year. The Update in Primary Immune Deficiency Diseases had an additional 151 delegates register to attend.
This year’s exhibit hall accommodated 17 exhibiting companies. Exhibiting companies included: Accredo Health Group, Axelacare, Baxter, Binding Site, Bio Products Laboratory, BioRx, Biotest Pharmaceuticals Corporation, CIS, CSL Behring, GeneDx, Georgetown University Immunology Center, Grifols, Medical College of Wisconsin, Vidara Therapeutics, ViroPharma, Inc., Walgreens Specialty Infusion, and World Allergy Organization.
CIS received 103 abstract submissions for the 2013 Annual Meeting. Of these abstracts, 11 were accepted for an oral presentation and 80 were accepted for poster presentations, 20 were included in the two guided poster sessions; in addition to the 34 invited speakers. The Update in PID accepted 8 oral presentations and 5 additional posters that were included in a guided poster session, in addition to the 10 invited speakers.
CIS would like to once again thank our 2013 Annual Meeting supporters:
- Alexion Pharmaceuticals
- Binding Site
- Bio Products Laboratory
- CSL Behring
- Jeffrey Modell Foundation
- Vidara Therapeutics
We hope you will join us for the 2014 CIS Annual Meeting: Primary Immune Deficiency Diseases North American Conference on April 10 – 13, 2014 in Baltimore, Maryland!